RxDoctor Payments Data

Stephanie Biscay, APRN

Family · Palm Coast, FLNPI 1942382130

Payments from drug & device makers

$996in general payments, 2019–2025

Across 46 payments — averaging $21.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$315
  • Takeda Pharmaceuticals U.S.A., Inc.$139
  • Madrigal Pharmaceuticals$111
  • Regeneron Healthcare Solutions, Inc.$98
  • Aimmune Therapeutics, Inc.$68
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$66
  • plus $198 from 6 others

What the payments were for

  • Food & beverage$996100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$996 in reported general payments places this provider in the 70th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$4,159
Medicare patients
21
Services billed
70

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban17$21,787
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$12,063
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$9,340
Albuterol Sulfate HfaAlbuterol Sulfate61$1,974
LantusInsulin Glargine,hum.Rec.Anlog11$1,303
Levothyroxine Sodium91$741
Rosuvastatin Calcium65$682
Gabapentin29$627
Pantoprazole Sodium70$434
Atorvastatin Calcium99$430
Tamsulosin Hcl36$377
Ezetimibe21$373
Duloxetine Hcl18$339
Fluticasone Propionate29$319
Losartan Potassium61$319

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$24$21,78717 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 14,618 family providers in Florida.

Other family in Palm Coast

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →